QCM
CPRX

Quantinno Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Quantinno Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
46,251
+12,366
+36% +$365K ﹤0.01% 2253
2026
Q1 		$839K Buy
33,885
+21,794
+180% +$519K ﹤0.01% 2308
2025
Q4 		$282K Buy
+12,091
New +$269K ﹤0.01% 2872

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quantinno Capital Management's CPRX Position: Q2 2026 in Review

Quantinno Capital Management increased its Catalyst Pharmaceutical (CPRX) stake by 36% in Q2 2026, buying an estimated $365K and bringing the position to 46,251 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2253.

Quantinno Capital Management first reported a position in CPRX in Q4 2025 and has held it in 3 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Quantinno Capital Management held 46,251 shares of Catalyst Pharmaceutical worth $1.45M as of Q2 2026.
  • Quantinno Capital Management bought 12,366 Catalyst Pharmaceutical shares in Q2 2026, an estimated $365K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2253 holding.
  • Quantinno Capital Management first reported a position in Catalyst Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.